Cargando…
IRX-2, a Novel Immunotherapeutic, Enhances Functions of Human Dendritic Cells
BACKGROUND: In a recent phase II clinical trial for HNSCC patients, IRX-2, a cell-derived biologic, promoted T-cell infiltration into the tumor and prolonged overall survival. Mechanisms responsible for these IRX-2-mediated effects are unknown. We hypothesized that IRX-2 enhanced tumor antigen-(TA)-...
Autores principales: | Schilling, Bastian, Harasymczuk, Malgorzata, Schuler, Patrick, Egan, James, Ferrone, Soldano, Whiteside, Theresa L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3567103/ https://www.ncbi.nlm.nih.gov/pubmed/23408925 http://dx.doi.org/10.1371/journal.pone.0047234 |
Ejemplares similares
-
IRX-2, a novel biologic, favors the expansion of T effector over T regulatory cells in a human tumor microenvironment model
por: Schilling, Bastian, et al.
Publicado: (2011) -
IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers
por: Wolf, Gregory T, et al.
Publicado: (2018) -
Irx3 and Irx5 - Novel Regulatory Factors of Postnatal Hypothalamic Neurogenesis
por: Dou, Zhengchao, et al.
Publicado: (2021) -
Site-Directed Mutagenesis of IRX9, IRX9L and IRX14 Proteins Involved in Xylan Biosynthesis: Glycosyltransferase Activity Is Not Required for IRX9 Function in Arabidopsis
por: Ren, Yanfang, et al.
Publicado: (2014) -
Three Novel Rice Genes Closely Related to the Arabidopsis
IRX9, IRX9L, and IRX14 Genes and Their Roles in Xylan Biosynthesis
por: Chiniquy, Dawn, et al.
Publicado: (2013)